Rizwan Ahmad

1.5k total citations · 1 hit paper
5 papers, 1.2k citations indexed

About

Rizwan Ahmad is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rizwan Ahmad has authored 5 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Rizwan Ahmad's work include Immune Response and Inflammation (2 papers), NF-κB Signaling Pathways (2 papers) and Dermatological and Skeletal Disorders (1 paper). Rizwan Ahmad is often cited by papers focused on Immune Response and Inflammation (2 papers), NF-κB Signaling Pathways (2 papers) and Dermatological and Skeletal Disorders (1 paper). Rizwan Ahmad collaborates with scholars based in Ireland, United States and United Kingdom. Rizwan Ahmad's co-authors include Averil Ma, Emre E. Turer, Osamu Hitotsumatsu, David L. Boone, Elizabeth M. McNally, Marcia Chien, Sophia Chai, Paula J. Hurley, Matthew T. Wheeler and Cecile M. Pickart and has published in prestigious journals such as Immunity, Nature Immunology and Clinical & Experimental Allergy.

In The Last Decade

Rizwan Ahmad

2 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

2004 889 citations David L. Boone, Emre E. Turer et al. Nature Immunology profile →

Peers

Countries citing papers authored by Rizwan Ahmad

Since Specialization

Citations

This map shows the geographic impact of Rizwan Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizwan Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizwan Ahmad more than expected).

Fields of papers citing papers by Rizwan Ahmad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rizwan Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizwan Ahmad. The network helps show where Rizwan Ahmad may publish in the future.

Co-authorship network of co-authors of Rizwan Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Rizwan Ahmad. A scholar is included among the top collaborators of Rizwan Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizwan Ahmad. Rizwan Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Analysing the role of ultraviolet A1 phototherapy in the treatment of primary cutaneous lichen amyloidosis in a patient with skin phototype 1 2025 ·Clinical Medicine ·(unknown), Rizwan Ahmad, (unknown), (unknown), John Ferguson	0
2	Paraprotein-Negative IL-1–Mediated Inflammatory Dermatosis: An Update on Schnitzler-Like Syndrome in the Absence of a Gammopathy 2025 ·JID Innovations ·Rizwan Ahmad, Jean Dunne, Katie Ridge, (unknown), (unknown)	0
3	Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response 2025 ·Clinical & Experimental Allergy ·Katie Ridge, Rizwan Ahmad, Barry Moran, Cliona O’Farrelly, Jean Dunne, Conor M. Finlay, Alan D. Irvine, (unknown)	0
4	The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered Signals 2008 ·Immunity ·Osamu Hitotsumatsu, Rizwan Ahmad, Rita M. Tavares, Min Wang, Dana J. Philpott, Emre E. Turer, Bettina L. Lee, (unknown), Rommel Advincula, Barbara A. Malynn, Catherine Werts, Averil Ma	280
5	The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses breakdown → 2004 ·Nature Immunology ·David L. Boone, Emre E. Turer, (unknown), Rizwan Ahmad, Matthew T. Wheeler, (unknown), Paula J. Hurley, Marcia Chien, Sophia Chai, Osamu Hitotsumatsu, Elizabeth M. McNally, Cecile M. Pickart, Averil Ma	889

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact